Cargando…

Comparison between obese and non-obese nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver conditions that are characterized by excess accumulation of fat in the liver, and is diagnosed after exclusion of significant alcohol intake and other causes of chronic liver disease. In the majority of cases, NAFLD is associat...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chan, Wah-Kheong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029940/ https://www.ncbi.nlm.nih.gov/pubmed/36472052 http://dx.doi.org/10.3350/cmh.2022.0350

Ejemplares similares

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li, Yifang, et al.
Publicado: (2021)

Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2022)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
por: Pitisuttithum, Panyavee, et al.
Publicado: (2020)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
por: Luo, Yunfei, et al.
Publicado: (2020)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt, Steven J, et al.
Publicado: (2014)

Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
por: Divella, Rosa, et al.
Publicado: (2019)

Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications
por: Wong, Sui‐Weng, et al.
Publicado: (2018)

Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents
por: Ued, Fábio da Veiga, et al.
Publicado: (2013)

The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
por: Ferolla, Silvia M., et al.
Publicado: (2014)

Metabolic status indicators and influencing factors in non-obese, non-centrally obese nonalcoholic fatty liver disease
por: Huang, Zhipeng, et al.
Publicado: (2023)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
por: Chandra Kumar, C. Vikneshwaran, et al.
Publicado: (2022)

The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
por: Arias-Loste, María Teresa, et al.
Publicado: (2015)

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
por: Song, Wolhwa, et al.
Publicado: (2023)

Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population
por: Li, Hui, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Comparison of Obesity-Related Indicators for Nonalcoholic Fatty Liver Disease Diagnosed by Transient Elastography
por: Tian, Xinyi, et al.
Publicado: (2023)

The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease
por: Feldman, Alexandra, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Karjoo, Sara, et al.
Publicado: (2022)

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
por: Jung, Un Ju, et al.
Publicado: (2014)

The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2017)

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
por: Chen, Yifei, et al.
Publicado: (2022)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
por: Oral, Alihan, et al.
Publicado: (2019)

Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer
por: Zhu, Chan-Yan, et al.
Publicado: (2019)

Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice
por: Tu, Lan N., et al.
Publicado: (2017)

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
por: Sun, Yue, et al.
Publicado: (2019)

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis
por: Kang, Seong Hee, et al.
Publicado: (2023)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review
por: Hashem, Anas, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls
por: Marin-Alejandre, Bertha Araceli, et al.
Publicado: (2019)

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Xu, Liang, et al.
Publicado: (2015)

Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease
por: Iwaki, Michihiro, et al.
Publicado: (2022)

Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity
por: Cordeiro, Adryana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iv4mmsp7p65ipinngqcmht11ft